Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Creager

Showing results (121-130 of 292) with videos related to

Pageof 30
Sort By:
Journal of the American College of Cardiology|October 8, 2021
High-Quality Peer Review of Clinical and Translational Research: A Practical GuideFred M Kusumoto, John A Bittl, Mark A Creager, et al.
Vascular Medicine (London, England)|February 1, 2020
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trialArman Qamar, David A Morrow, Mark A Creager, et al.
Circulation|August 11, 2020
Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and HaemostasisMary Cushman, Geoffrey D Barnes, Mark A Creager, et al.
Journal of Vascular Surgery|July 22, 2008
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) RegistryIris Baumgartner, Alan T Hirsch, Maria Teresa B Abola, et al.
Journal of the American College of Cardiology|October 2, 2002
Homocysteine impairs coronary microvascular dilator function in humansAhmed Tawakol, Marc A Forgione, Markus Stuehlinger, et al.
Diabetes Care|October 17, 2013
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD)Allison B Goldfine, J Stewart Buck, Cyrus Desouza, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and HaemostasisMary Cushman, Geoffrey D Barnes, Mark A Creager, et al.
Obesity (Silver Spring, Md.)|June 23, 2009
Acute effects of dietary glycemic index on antioxidant capacity in a nutrient-controlled feeding studyDiego Botero, Cara B Ebbeling, Jeffrey B Blumberg, et al.
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
Circulation|May 8, 2020
Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart AssociationPeter K Henke, Susan R Kahn, Christopher J Pannucci, et al.
Pageof 30

Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Journal of the American College of Cardiology|October 8, 2021
High-Quality Peer Review of Clinical and Translational Research: A Practical GuideFred M Kusumoto, John A Bittl, Mark A Creager, et al.
Vascular Medicine (London, England)|February 1, 2020
Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trialArman Qamar, David A Morrow, Mark A Creager, et al.
Circulation|August 11, 2020
Venous Thromboembolism Research Priorities: A Scientific Statement From the American Heart Association and the International Society on Thrombosis and HaemostasisMary Cushman, Geoffrey D Barnes, Mark A Creager, et al.
Journal of Vascular Surgery|July 22, 2008
Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) RegistryIris Baumgartner, Alan T Hirsch, Maria Teresa B Abola, et al.
Journal of the American College of Cardiology|October 2, 2002
Homocysteine impairs coronary microvascular dilator function in humansAhmed Tawakol, Marc A Forgione, Markus Stuehlinger, et al.
Diabetes Care|October 17, 2013
Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD)Allison B Goldfine, J Stewart Buck, Cyrus Desouza, et al.
Research and Practice in Thrombosis and Haemostasis|July 21, 2020
Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and HaemostasisMary Cushman, Geoffrey D Barnes, Mark A Creager, et al.
Obesity (Silver Spring, Md.)|June 23, 2009
Acute effects of dietary glycemic index on antioxidant capacity in a nutrient-controlled feeding studyDiego Botero, Cara B Ebbeling, Jeffrey B Blumberg, et al.
Circulation|September 28, 2011
Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudicationMark A Creager, Jeffrey W Olin, Jill J F Belch, et al.
Circulation|May 8, 2020
Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart AssociationPeter K Henke, Susan R Kahn, Christopher J Pannucci, et al.
Pageof 30